Pharma-bio Serv's Business Segments

Pharma-Bio Serv, Inc., a Delaware corporation founded in 2004, provides technical compliance consulting services primarily to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, and food industries. The company operates mainly in Puerto Rico, the United States, Europe, and Brazil. Its services include regulatory affairs, quality, compliance, and technology transfer consulting. The consulting team consists of engineers, life science experts, former quality assurance managers, and former health agency officials. Pharma-Bio’s revenue is primarily generated from time and materials contracts, with a smaller portion from fixed-fee contracts. The company manages labor costs through consultant selection, rate negotiations, subcontracting, and passing rate increases to clients. Pharma-Bio maintains quality systems such as training programs, safety programs, and a code of ethics and business conduct. It operates three reportable segments: Puerto Rico, United States, and Europe technical compliance consulting. The company’s growth strategy focuses on expanding services in the U.S., Europe, and Latin America by leveraging established relationships with major pharmaceutical and related companies. Its objectives include growing consulting services, enhancing technical offerings, motivating staff through performance-based compensation, fostering a positive corporate culture, maintaining a trustworthy reputation, and managing costs efficiently.

The registrant's reportable segments include Puerto Rico technical compliance consulting, United States technical compliance consulting, and Europe technical compliance consulting. Financial information for these segments is provided in Note J to the Consolidated Financial Statements in the Annual Report on Form 10-K.